In vitro, the level of MMP produced by IL-lβ-stimulated human RA-FLS is reduced by anti-TRAF6 monoclonal antibodies, significantly inhibiting the migration and invasion of RA-FLS [117]. This evidence concerns the gene TRAF6 and rheumatoid arthritis.